EcoDrugPlus

Renin

Ensembl ID : ENSBBBG00000017030
Gene Symbol: REN
3 Cross references
220 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSBBBG00000012637
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSBBBG00000024732
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSBBBG00000011789
Gene Symbol: RARB
3 Cross references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSBBBG00000019817
Gene Symbol: RARG
3 Cross references
451 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSBBBG00000015089
Gene Symbol: RXRB
3 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSBBBG00000012757
Gene Symbol: RXRG
3 Cross references
277 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSBBBG00000013708
Gene Symbol: RPL10A
3 Cross references
208 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSBBBG00000001179
Gene Symbol: RPL11
3 Cross references
196 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSBBBG00000020437
Gene Symbol: RPL12
3 Cross references
192 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSBBBG00000016199
Gene Symbol: RPL13
3 Cross references
246 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSBBBG00000021617
Gene Symbol: RPL14
3 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).